Investing.com -- Weight Watchers (NASDAQ:WW) shares rose 17% Thursday after the company announced it will offer Eli Lilly and Company’s newly FDA-approved oral GLP-1 medication Foundayo (orforglipron) ... Markets Insider: Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, announced that it is now offering access to Eli Lilly and Company’s newly FDA-approved ...

Understanding the Context

Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect Investing.com India: Weight Watchers stock jumps on new Eli Lilly GLP-1 offering Weight Watchers has established an interim office of the CEO, with Chief Financial Officer Felicia DellaFortuna and Chief Operations Officer Jon Volkmann serving as principal offi ... MarketWatch on MSN: Here’s how much weight-loss drugs Wegovy, Zepbound and Foundayo cost — and how to pick the best GLP-1 for you The GLP-1 market is growing fast. Here’s how much the most popular medications will cost you.